Viveve Medical Named One of North America's Fastest Growing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
51
Viveve Medical Named One of North America's Fastest Growing Companies

ENGLEWOOD, CO --(Marketwired - December 12, 2017) - Viveve Medical Inc. ( NASDAQ : VIVE ), a medical technology company focused on women's health and wellness, today announced that the company has been included in Deloitte's 2017 Technology Fast 500, a list of the 500 fastest growing technology, media, telecommunications, life sciences and energy technology companies in North America.

"We are honored that Viveve has been named to the 2017 Technology Fast 500 ranking, which we believe reflects the hard work of our entire team and the tremendous global response to our patented Viveve System technology platform," said Patricia Scheller, chief executive officer of Viveve.

The Viveve System is supported by a global distribution network in 69 countries and an IP estate of 60 U.S. and international patents. In the United States, the GENEVEVE™ treatment is cleared by the U.S. Food and Drug Administration for general surgical procedures for electrocoagulation and hemostasis. In 56 countries around the world the Viveve System is approved for the treatment of vaginal laxity and/or the improvement of sexual function.

About Viveve Viveve Medical, Inc. is a women's health and wellness company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System, that delivers the GENEVEVE™ treatment, incorporates clinically-proven cryogen-cooled, monopolar radiofrequency (CMRF) energy-based technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate robust neocollagenesis in one 30-minute in-office session.

International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications from over 55 countries. Consistent with these approvals, Viveve is seeking an IDE from the FDA to conduct a pivotal study on use of the device for improvement in sexual function. Currently, in the United States, the Viveve System is cleared by the FDA for general surgical procedures for electrocoagulation and hemostasis.

InControl Products by Viveve are FDA cleared medical devices that treat stress, urge, and mixed incontinence conditions and products to improve pelvic floor strength. Viveve exclusively distributes InControl Medical's products to healthcare providers in the United States.

For more information visit Viveve's website at www.viveve.com .

Safe Harbor Statement All statements in this press release that are not based on historical fact are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. While management has based any forward-looking statements included in this press release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic and current reports available for review at www.sec.gov . Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Viveve is a registered trademark of Viveve, Inc. Geneveve is a trademark of Viveve, Inc.

Investor Relations contacts: Sarah McCabe Stern Investor Relations, Inc. (212) 362-1200 sarah@sternir.com Amato and Partners, LLC Investor Relations Counsel admin@amatoandpartners.com Media contact: Sara Zelkovic Berry & Company Public Relations (212) 253-8881 szelkovic@berrypr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 237

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 136

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
GALLS Honors Service With Lexington Hall of Fame Wall

Updated Category News Views 86

A headquarters wall can say more about a company than another polished mission statement ever will. On November 17, 2026, GALLS® unveiled the National Law Enforcement Officer Hall of Fame Wall at its Lexington, Kentucky, corporate headquarters, displaying portraits of every past inductee into the National Law Enforcement Officer Hall of Fame. Recognition, made permanent...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 86

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 58

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 115

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 32

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 147

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 183

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 107

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading

Top 5 Most Recently Viewed Articles

Coway's Inverter Dehumidifier 23L Triumphs at Global Design Awards

Updated Category News Views 208

Inverter Dehumidifier 23L Wins Recognition at Good Design Awards - The Inverter Dehumidifier 23L gains accolades for its compact design and user-friendly features at the Good Design Awards 2025. - This recent achievement cements Coway's status as a leading player in global design, recognized by all four major awards this year. Coway's Prestigious Award Recognition Hosted...

Continue Reading
Veru's Enobosarm & Semaglutide: A New Era in Weight Loss Safety

Updated Category News Views 314

Positive Safety Profile from Veru's Clinical Study Veru Inc. (NASDAQ: VERU), a trailblazer in biopharmaceuticals, recently revealed exciting topline safety results from its Phase 2b QUALITY clinical study. This trial examined the combination of enobosarm and semaglutide, uncovering significant advantages in safety and efficacy compared to semaglutide alone. Understanding...

Continue Reading
How a $1000 Investment in REV Group Can Grow Over Time

Updated Category News Views 180

Understanding REV Group's Market Performance REV Group (NYSE: REVG) has demonstrated impressive performance in the stock market over the past five years. This company has not only outperformed the broader market, but it has done so by a remarkable 29.45% on an annualized basis, resulting in an average annual return of 42.83%. With a market capitalization reaching...

Continue Reading
Castellum's GTMR Achieves Key CMMI Level 3 Milestone

Updated Category News Views 172

Castellum's GTMR Achieves Key CMMI Level 3 Milestone Castellum, Inc. (NYSE-American: CTM) has exciting news to share, as it announces its subsidiary, Global Technology and Management Resources, Inc. (GTMR), has achieved a significant milestone by obtaining a Level 3 appraisal under ISACA’s Capability Maturity Model Integration (CMMI). This recognition highlights GTMR's...

Continue Reading
Discovering Nature Close Up: The MicroCam X1 Launch

Updated Category News Views 162

Introducing the MicroCam X1 by Littpopo Littpopo, an innovative brand dedicated to exploration technology, has launched the MicroCam X1, a remarkable pocket microscope camera now live on a crowdfunding platform. This unique device combines a powerful 400X microscope with a 4K camera, making it an essential tool for educators, content creators, families, and adventurers...

Continue Reading